Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Jun;46(6):1695-703.
doi: 10.1128/AAC.46.6.1695-1703.2002.

Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis

Affiliations

Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis

Sofia Perea et al. Antimicrob Agents Chemother. 2002 Jun.

Abstract

Candida dubliniensis is a newly identified species of Candida that is phenotypically similar to but genetically distinct from C. albicans. This organism has been recovered with increasing frequency from the oral cavities of human immunodeficiency virus (HIV)-infected and AIDS patients and has been implicated as a causative agent of oral candidiasis and systemic disease. In the present study we characterized the molecular mechanisms of resistance to fluconazole (FLC) in C. dubliniensis clinical isolates from two different HIV-infected patients with oropharyngeal candidiasis. Isolates were identified to the species level by phenotypic and genotypic tests. DNA-typing techniques were used to assess strain identity. Antifungal susceptibility testing was performed by NCCLS techniques. Northern blotting analysis was used to monitor the expression of genes encoding lanosterol demethylase (ERG11) and efflux transporters (CDR and MDR1) in matched sets of C. dubliniensis-susceptible and -resistant isolates by using probes generated from their homologous C. albicans sequences. In addition, ERG11 genes were amplified by PCR, and their nucleotide sequences were determined in order to detect point mutations with a possible effect in the affinity for azoles. Decreasing susceptibilities to FLC were detected in C. dubliniensis isolates recovered from both patients during the course of treatment. FLC-resistant C. dubliniensis isolates from one patient demonstrated combined upregulation of the MDR1, CDR1, and ERG11 genes. Among the isolates from the second patient, all isolates showing decreased susceptibility to FLC demonstrated upregulation of MDR1, whereas the levels of mRNA for the ERG11 genes remained constant and the expression of CDR genes was negligible. Fourteen point mutations were found in the ERG11 genes of the isolates with decreased susceptibility to FLC. These data demonstrate that the development of azole resistance in C. dublinensis clinical isolates from HIV-infected patients treated with FLC is mediated by multiple molecular mechanisms of resistance, similar to the observations found in the case of C. albicans.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
(A and C) Patient 1. (A) Karyotyping; (C) fingerprinting analysis of EcoRI digests with the Cd25 probe. Lanes CA, C. albicans reference strain 3153A; lanes CD, C. dubliniensis reference strain NCPF 3949; the remaining lanes contain clinical isolates of C. dubliniensis. (B and D) Patient 2. (B) Karyotyping; (D) fingerprinting analysis of EcoRI digests with the Cd25 probe. Lanes CA, C. albicans reference strain 3153A; lanes CD, C. dubliniensis reference strain NCPF 3949; the remaining lanes contain clinical isolates of C. dubliniensis. FLU, fluconazole.
FIG. 2.
FIG. 2.
(A and B) Northern analysis of total RNA from C. dubliniensis clinical isolates from patients 1 and 2 with ERG11, MDR1, and CDR genes from C. albicans as probes. (C and D) The signal intensities of the levels of mRNA for CDR, MDR1, and ERG11 were quantified densitometrically and normalized to the intensity of the susceptible isolate. 18S rRNA was used to standardize signal levels according to lane loading parameters. Flu, fluconazole.
FIG.3.
FIG.3.
Nucleotide sequence and deduced amino acid sequence of C. dubliniensis lanosterol 14α-demethylase. ∗, stop codon.

Similar articles

Cited by

References

    1. Boscot, P. E., and G. H. Grant. 1994. Modelying cytochrome P450 14α-demethylase (Candida albicans) from P450cam. J. Mol. Graphics 12:185-195. - PubMed
    1. Brandt, M. E., L. H. Harrison, M. Pass, A. N. Sofair, S. Huie, R. K. Li, C. J. Morrison, and D. W. Warnock. 2000. Candida dubliniensis fungemia: the first four cases in North America. Emerg. Infect. Dis. 6:46-49. - PMC - PubMed
    1. Brown, D. M., M. A. Jabra-Rizk, W. A. Falker, A. A. Baqui, and T. F. Meiller. 2000. Identification of Candida dublinienis in a study of HIV-seropositive pediatric dental patients. Pediatr. Dent. 22:234-238. - PubMed
    1. Coleman, D., D. Sullivan, B. Harrington, K. Haynes, M. Henman, D. Shanley, D. Bennett, G. Moran, C. McCreary, and L. O'Neill. 1997. Molecular and phenotypic analysis of Candida dubliniensis: a recent identified species linked with oral candidosis in HIV-infected and AIDS patients. Oral Dis. 1:96-101. - PubMed
    1. Coleman, D. C., D. J. Sullivan, D. E. Bennett, G. P. Moran, H. J. Barry, and D. B. Shanley. 1997. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 11:557-567. - PubMed

Publication types

MeSH terms